Fig. 6
From: Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
External validation of OS and PFS signatures. (a, f) Time-dependent ROC curves of the OS and PFS signatures at 1, 2, and 3 years. (b, g) Kaplan–Meier survival curves showing the differences of OS and PFS between low-risk and high-risk patients. (c, h) Gene expression levels of the high-risk and low-risk groups with the OS and PFS signatures. (d, i) OS and PFS scatter plots for sarcoma patients. (e, j) Risk score distribution of patients with the OS and PFS signatures. OS Overall survival, PFS Progression-free survival, ROC Receiver operating characteristic